NCT01083485View on ClinicalTrials.gov

OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

November 30, 2010

Conditions
Post Operative Pain
Interventions
DRUG

Oxycodone/Naloxone PR 20/10mg or 10/5mg tablets

Oxycodone/Naloxone prolonged release 20/10mg or 10/5mg tabs twice a day (BID) for 2.5 days (total 5 dosages)or Oxycodone 20mg

DRUG

Oxycodone

Oxycodone 20mg or 10mg BID for 2.5 days (total 5 dosages)

Trial Locations (1)

28500

Central hospital of Pori, Pori

Sponsors

Lead Sponsor

Mundipharma Oy
All Listed Sponsors
lead

Mundipharma Oy

INDUSTRY